Leerink Partners Starts Benitec BioPharma (BNTC) at Outperform
Tweet
Share
E-mailGet Alerts BNTC Hot Sheet
Price: $13.07 +4.06%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar initiates coverage on Benitec BioPharma (NASDAQ: BNTC) with a Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Benitec BioPharma click here. For more ratings news on Benitec BioPharma click here.
Shares of Benitec BioPharma closed at $9.22 yesterday.
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- BTIG Starts Freenome Inc. (FRNM) at Buy
- Goldman Sachs Resumes Luxshare Precision (002475:CH) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
